(2R,3S)-N-[(2S)-4-[[4-[(E)-hydroxyiminomethyl]phenyl]sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-3-methyl-2-[3-[(3-methylimidazo[4,5-b]pyridin-2-yl)methyl]-2-oxoimidazolidin-1-yl]pentanamide

C38H50N8O5S — CID 89103583

IUPAC(2R,3S)-N-[(2S)-4-[[4-[(E)-hydroxyiminomethyl]phenyl]sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-3-methyl-2-[3-[(3-methylimidazo[4,5-b]pyridin-2-yl)methyl]-2-oxoimidazolidin-1-yl]pentanamide
SMILESCC[C@H](C)[C@H](C(=O)N[C@H](CCN(CC(C)C)S(=O)(=O)c1ccc(/C=N/O)cc1)Cc1ccccc1)N1CCN(Cc2nc3cccnc3n2C)C1=O
InChIInChI=1S/C38H50N8O5S/c1-6-28(4)35(46-22-21-44(38(46)48)26-34-42-33-13-10-19-39-36(33)43(34)5)37(47)41-31(23-29-11-8-7-9-12-29)18-20-45(25-27(2)3)52(50,51)32-16-14-30(15-17-32)24-40-49/h7-17,19,24,27-28,31,35,49H,6,18,20-23,25-26H2,1-5H3,(H,41,47)/b40-24+/t28-,31+,35+/m0/s1
InChIKeyMGCLAPFUQKILIR-HMFUNPFDSA-N
MW730.94 g/mol
LogP4.89
Rot. Bonds17

About (2R,3S)-N-[(2S)-4-[[4-[(E)-hydroxyiminomethyl]phenyl]sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-3-methyl-2-[3-[(3-methylimidazo[4,5-b]pyridin-2-yl)methyl]-2-oxoimidazolidin-1-yl]pentanamide

(2R,3S)-N-[(2S)-4-[[4-[(E)-hydroxyiminomethyl]phenyl]sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-3-methyl-2-[3-[(3-methylimidazo[4,5-b]pyridin-2-yl)methyl]-2-oxoimidazolidin-1-yl]pentanamide (PubChem CID 89103583) has the molecular formula C38H50N8O5S and a molecular weight of 730.94 g/mol. Its IUPAC name is (2R,3S)-N-[(2S)-4-[[4-[(E)-hydroxyiminomethyl]phenyl]sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-3-methyl-2-[3-[(3-methylimidazo[4,5-b]pyridin-2-yl)methyl]-2-oxoimidazolidin-1-yl]pentanamide.

Molecular Properties

Compound Name(2R,3S)-N-[(2S)-4-[[4-[(E)-hydroxyiminomethyl]phenyl]sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-3-methyl-2-[3-[(3-methylimidazo[4,5-b]pyridin-2-yl)methyl]-2-oxoimidazolidin-1-yl]pentanamide
PubChem CID89103583
Molecular FormulaC38H50N8O5S
Molecular Weight730.94 g/mol
Exact Mass730.36
IUPAC Name(2R,3S)-N-[(2S)-4-[[4-[(E)-hydroxyiminomethyl]phenyl]sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-3-methyl-2-[3-[(3-methylimidazo[4,5-b]pyridin-2-yl)methyl]-2-oxoimidazolidin-1-yl]pentanamide
SMILESCC[C@H](C)[C@H](C(=O)N[C@H](CCN(CC(C)C)S(=O)(=O)c1ccc(/C=N/O)cc1)Cc1ccccc1)N1CCN(Cc2nc3cccnc3n2C)C1=O
InChIInChI=1S/C38H50N8O5S/c1-6-28(4)35(46-22-21-44(38(46)48)26-34-42-33-13-10-19-39-36(33)43(34)5)37(47)41-31(23-29-11-8-7-9-12-29)18-20-45(25-27(2)3)52(50,51)32-16-14-30(15-17-32)24-40-49/h7-17,19,24,27-28,31,35,49H,6,18,20-23,25-26H2,1-5H3,(H,41,47)/b40-24+/t28-,31+,35+/m0/s1
InChIKeyMGCLAPFUQKILIR-HMFUNPFDSA-N
XLogP4.89
TPSA153.33 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds17
Heavy Atoms52
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500730.94
LogP ≤ 54.89
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'oxime_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze (2R,3S)-N-[(2S)-4-[[4-[(E)-hydroxyiminomethyl]phenyl]sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-3-methyl-2-[3-[(3-methylimidazo[4,5-b]pyridin-2-yl)methyl]-2-oxoimidazolidin-1-yl]pentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R,3S)-N-[(2S)-4-[[4-[(E)-hydroxyiminomethyl]phenyl]sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-3-methyl-2-[3-[(3-methylimidazo[4,5-b]pyridin-2-yl)methyl]-2-oxoimidazolidin-1-yl]pentanamide?
The IUPAC name of (2R,3S)-N-[(2S)-4-[[4-[(E)-hydroxyiminomethyl]phenyl]sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-3-methyl-2-[3-[(3-methylimidazo[4,5-b]pyridin-2-yl)methyl]-2-oxoimidazolidin-1-yl]pentanamide (CID 89103583) is (2R,3S)-N-[(2S)-4-[[4-[(E)-hydroxyiminomethyl]phenyl]sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-3-methyl-2-[3-[(3-methylimidazo[4,5-b]pyridin-2-yl)methyl]-2-oxoimidazolidin-1-yl]pentanamide.
What is the SMILES notation for (2R,3S)-N-[(2S)-4-[[4-[(E)-hydroxyiminomethyl]phenyl]sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-3-methyl-2-[3-[(3-methylimidazo[4,5-b]pyridin-2-yl)methyl]-2-oxoimidazolidin-1-yl]pentanamide?
The canonical SMILES for (2R,3S)-N-[(2S)-4-[[4-[(E)-hydroxyiminomethyl]phenyl]sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-3-methyl-2-[3-[(3-methylimidazo[4,5-b]pyridin-2-yl)methyl]-2-oxoimidazolidin-1-yl]pentanamide is CC[C@H](C)[C@H](C(=O)N[C@H](CCN(CC(C)C)S(=O)(=O)c1ccc(/C=N/O)cc1)Cc1ccccc1)N1CCN(Cc2nc3cccnc3n2C)C1=O.
What is the InChIKey of (2R,3S)-N-[(2S)-4-[[4-[(E)-hydroxyiminomethyl]phenyl]sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-3-methyl-2-[3-[(3-methylimidazo[4,5-b]pyridin-2-yl)methyl]-2-oxoimidazolidin-1-yl]pentanamide?
The InChIKey is MGCLAPFUQKILIR-HMFUNPFDSA-N. The full InChI is InChI=1S/C38H50N8O5S/c1-6-28(4)35(46-22-21-44(38(46)48)26-34-42-33-13-10-19-39-36(33)43(34)5)37(47)41-31(23-29-11-8-7-9-12-29)18-20-45(25-27(2)3)52(50,51)32-16-14-30(15-17-32)24-40-49/h7-17,19,24,27-28,31,35,49H,6,18,20-23,25-26H2,1-5H3,(H,41,47)/b40-24+/t28-,31+,35+/m0/s1.
What are the key properties of (2R,3S)-N-[(2S)-4-[[4-[(E)-hydroxyiminomethyl]phenyl]sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-3-methyl-2-[3-[(3-methylimidazo[4,5-b]pyridin-2-yl)methyl]-2-oxoimidazolidin-1-yl]pentanamide?
(2R,3S)-N-[(2S)-4-[[4-[(E)-hydroxyiminomethyl]phenyl]sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-3-methyl-2-[3-[(3-methylimidazo[4,5-b]pyridin-2-yl)methyl]-2-oxoimidazolidin-1-yl]pentanamide has a molecular weight of 730.94 g/mol, XLogP of 4.89, 17 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,3S)-N-[(2S)-4-[[4-[(E)-hydroxyiminomethyl]phenyl]sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-3-methyl-2-[3-[(3-methylimidazo[4,5-b]pyridin-2-yl)methyl]-2-oxoimidazolidin-1-yl]pentanamide is sourced from PubChem (CID 89103583), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).